226 related articles for article (PubMed ID: 22799029)
21. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
Ge Y; Li A; Wu J; Feng H; Wang L; Liu H; Xu Y; Xu Q; Zhao L; Li Y
Eur J Med Chem; 2017 Mar; 128():180-191. PubMed ID: 28182990
[TBL] [Abstract][Full Text] [Related]
22. α-Keto phenylamides as P1'-extended proteasome inhibitors.
Voss C; Scholz C; Knorr S; Beck P; Stein ML; Zall A; Kuckelkorn U; Kloetzel PM; Groll M; Hamacher K; Schmidt B
ChemMedChem; 2014 Nov; 9(11):2557-64. PubMed ID: 25087721
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids.
Shi J; Lei M; Wu W; Feng H; Wang J; Chen S; Zhu Y; Hu S; Liu Z; Jiang C
Bioorg Med Chem Lett; 2016 Apr; 26(8):1958-62. PubMed ID: 26965867
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of peptidyl epoxyketone proteasome inhibitors composed of β-amino acids.
Zhang J; Han M; Ma X; Xu L; Cao J; Zhou Y; Li J; Liu T; Hu Y
Chem Biol Drug Des; 2014 Nov; 84(5):497-504. PubMed ID: 24751157
[TBL] [Abstract][Full Text] [Related]
25. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
[TBL] [Abstract][Full Text] [Related]
26. α- and β-hydrazino acid-based pseudopeptides inhibit the chymotrypsin-like activity of the eukaryotic 20S proteasome.
Bordessa A; Keita M; Maréchal X; Formicola L; Lagarde N; Rodrigo J; Bernadat G; Bauvais C; Soulier JL; Dufau L; Milcent T; Crousse B; Reboud-Ravaux M; Ongeri S
Eur J Med Chem; 2013; 70():505-24. PubMed ID: 24185380
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel Proteasome Inhibitors from an Enaminone Library.
Elliott ML; Thomas K; Kennedy S; Koduri ND; Hussaini RS; Sheaff RJ
Chem Biol Drug Des; 2015 Sep; 86(3):322-32. PubMed ID: 25494709
[TBL] [Abstract][Full Text] [Related]
29. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361
[TBL] [Abstract][Full Text] [Related]
30. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.
Zhang W; Bai H; Han L; Zhang H; Xu B; Cui J; Wang X; Ge Z; Li R
Bioorg Med Chem Lett; 2018 Aug; 28(14):2459-2464. PubMed ID: 29886021
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
Zhang J; Shen L; Wang J; Luo P; Hu Y
Med Chem; 2014; 10(1):38-45. PubMed ID: 23676009
[TBL] [Abstract][Full Text] [Related]
34. Proteasome inhibitors with photocontrolled activity.
Hansen MJ; Velema WA; de Bruin G; Overkleeft HS; Szymanski W; Feringa BL
Chembiochem; 2014 Sep; 15(14):2053-7. PubMed ID: 25125335
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.
Xu Y; Yang X; Chen Y; Chen H; Sun H; Li W; Xie Q; Yu L; Shao L
Bioorg Med Chem Lett; 2018 Jul; 28(12):2148-2152. PubMed ID: 29773504
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2006 Aug; 41(8):978-84. PubMed ID: 16713026
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and SAR study of novel peptide aldehydes as inhibitors of 20S proteasome.
Ma Y; Xu B; Fang Y; Yang Z; Cui J; Zhang L; Zhang L
Molecules; 2011 Sep; 16(9):7551-64. PubMed ID: 21894088
[TBL] [Abstract][Full Text] [Related]
38. C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors.
Franceschini C; Trapella C; Calia R; Scotti A; Sforza F; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1034-9. PubMed ID: 22871133
[TBL] [Abstract][Full Text] [Related]
39. Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators.
Coleman RA; Trader DJ
ACS Comb Sci; 2018 May; 20(5):269-276. PubMed ID: 29553711
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.
Li A; Sun H; Du L; Wu X; Cao J; You Q; Li Y
J Mol Model; 2014 Nov; 20(11):2515. PubMed ID: 25394401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
